# Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR

> **NCT07178652** · — · NOT_YET_RECRUITING · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 2325 (estimated)

## Conditions studied

- Preeclampsia (PE) Risk
- Oocyte Donation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07178652
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-12
- **Final completion:** 2029-08
- **Target enrollment:** 2325 (ESTIMATED)
- **Last updated:** 2025-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07178652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07178652, "Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07178652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
